Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
RABORAL V-RG
- Development stage
- Unknown
- Lead developer
- Boehringer Ingelheim
- Modality
- Viral Vectors → Gene Addition/Replacement → Gene Therapies, Vaccines & Immunotherapeutics
- Administration
- Oral
01
Overview
RABORAL V-RG is an oral recombinant vaccine designed for the mass immunization of wildlife against rabies. Developed by Boehringer Ingelheim (formerly Merial), the vaccine utilizes a live vaccinia virus vector that has been genetically engineered to express the rabies virus glycoprotein (G protein). When ingested by target species such as raccoons, coyotes, or foxes via edible baits, the vaccine induces a protective immune response against rabies virus infection. It is a critical tool in public health programs aimed at controlling and eliminating specific rabies variants in wild animal populations across North America and Europe. The vaccine is distributed exclusively to government agencies and is not available for purchase by the general public.
- Brand names
- RABORAL V-RG
- Other names
- Rabies vaccine, live vaccinia vectorRABORAL
02
Targets
RABV-G (Rabies virus glycoprotein)
Beyond the preview
Go deeper on RABORAL V-RG.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RABORAL V-RG.